Table 1—

Baseline characteristics of the study population

Entire cohortNo metabolic syndrome by either ATPIII or WHO criteriaMetabolic syndrome by both ATP III and WHO criteria
n2,1751,430323
African American (%)9.95.932.11
Age (years)73 ± 573 ± 573 ± 5
Male sex (%)57.658.755.3
Current smoking (%)13.913.514.9
Family history of MI (%)29.027.932.5
Waist (cm)*92.7 ± 11.689.9 ± 11.1101.8 ± 9.8
Hip (cm)*100.8 ± 8.099.4 ± 7.5106.4 ± 7.9
Waist-to-hip ratio*0.92 ± 0.080.90 ± 0.080.96 ± 0.07
BMI (kg/m2)*26.0 ± 3.825.1 ± 3.529.0 ± 3.6
SBP (mmHg)*136.4 ± 18.9133.9 ± 18.9143.8 ± 18.4
DBP (mmHg)*71.2 ± 9.870.4 ± 9.773.7 ± 10.2
Pulse pressure (mmHg)*65.2 ± 16.763.6 ± 16.770.0 ± 17.1
Fasting plasma glucose (mg/dl)*104.9 ± 26.996.3 ± 8.1141.2 ± 48.0
Triglycerides (mg/dl)*129.6 ± 65.9110.7 ± 42.7181.3 ± 100.0
HDL cholesterol (mg/dl)*56.5 ± 16.060.4 ± 15.647.4 ± 13.1
LDL cholesterol (mg/dl)129.8 ± 35.1128.7 ± 33.8130.1 ± 36.6
CCA IMT (mm)*0.99 ± 0.230.97 ± 0.231.06 ± 0.24
CCA diameter (mm)*9.06 ± 0.948.96 ± 0.949.34 ± 0.95
  • Data are means ± SD.

  • *

    * P < 0.001 for no metabolic syndrome vs. metabolic syndrome. CCA, common carotid artery; DBP, diastolic blood pressure; MI, myocardial infarction; SBP, systolic blood pressure.